Ivermectin May Help Post-COVID and Vaccine-Induced Chronic Fatigue Syndrome: Expert

Ivermectin May Help Post-COVID and Vaccine-Induced Chronic Fatigue Syndrome: Expert
(Shutterstock)
George Citroner
1/14/2023
Updated:
9/19/2023
0:00

Chronic fatigue syndrome (CFS), also called myalgic encephalomyelitis, can leave sufferers feeling tired, even after sleep, and may lead to problems with memory and concentration.

CFS cases have exploded during the COVID-19 pandemic and some doctors are using novel methods to treat the condition—including ivermectin, which was called a “wonder drug” for human health before the pandemic.

Nearly 80 Percent Report Post-COVID CFS

A recent questionnaire-based study published in the journal Neurology International found that nearly 80 percent of patients with COVID-19 had one or more persistent symptoms post-infection and 58 percent met the case definition for CFS.
Another analysis published by Fair Health showed that CFS was most common in those with severe COVID-19, but even among asymptomatic infections, 1 in 5 reported the condition.
CFS had been described as early as 1934 and was associated with the Epstein-Barr virus in the ’80s.
Before developing symptoms, patients most frequently reported experiencing severe illness, surgery, an accident, or physical, psychological, or emotional trauma.

“Post-COVID fatigue and myalgic encephalomyelitis are two disorders that have a tremendous amount of overlap,” Dr. Thomas Gut, medical director of the Post-COVID Recovery Center at Staten Island University Hospital, part of Northwell Health in New York, told The Epoch Times.

Post-COVID-19 CFS, a condition that can be a symptom of long COVID, is characterized by prolonged, generalized, and abnormal fatigue after exercise that doesn’t resolve after rest; recurrent headaches; and problems with concentration and memory that have lasted for at least six months.

It may be accompanied by other symptoms, such as tender lymph nodes, musculoskeletal pain, sleep disruption, and psychiatric problems.

The condition has also been identified as a potential adverse reaction to being vaccinated against COVID-19.

CFS and its painful cousin fibromyalgia represent the “tripping of a circuit breaker” in the part of the brain called the hypothalamus, Dr. Jacob Teitelbaum, a board-certified internist and nationally known expert in the fields of chronic fatigue syndrome, fibromyalgia, sleep, and pain, told The Epoch Times.

“It is not enough to simply turn the circuit breaker back on,” Teitelbaum said. “You also need to address what caused the circuit breaker to overload, and this varies dramatically from cause to cause.”

He pointed out that CFS can occur as a result of numerous stressors or after one of many infections besides COVID-19. These include:
  • A stressful job or relationship
  • Hormonal issues
  • Other chronic infections
  • Autoimmune disease
Gut added that currently, the causes of long COVID and most post-COVID-19 neurocognitive changes are poorly understood and don’t have a clear mechanism to explain the symptoms.
“There are many centers for treatment in the United States that have had some promising results in helping patients cope or alleviate some symptoms, but the approaches vary widely,” Gut said. “Unfortunately, we’re in the infancy of long-COVID research, and very few established treatment options exist outside of dedicated COVID recovery programs.”

Ivermectin May Help Post-COVID and Post-Vaccine CFS

Ivermectin could help those living with post-COVID-19 CFS, Teitelbaum said.
Research finds that ivermectin can be helpful during COVID-19 infection, despite the controversy surrounding it. It shows promise for treatments specific to long COVID as well.
A recently completed clinical trial by drugmaker MedinCell evaluated the safety and efficacy of ivermectin tablets that were taken orally for 28 days, under the oversight of a U.S.-based independent data monitoring committee.

Participants in the ivermectin group showed a statistically significant reduction of 72 percent in laboratory-confirmed infections between day 1 and day 28, versus a placebo.

No adverse effects were associated with a daily intake of ivermectin of 200 microgram/kg on day 1, or of 100 microgram/kg daily from day 2 to day 28, during the study.

However, people should be careful when taking ivermectin, since some are allergic to it, and potential side effects can include nausea, dizziness, and chest discomfort.

“It was unexpected,” Teitelbaum said, “but we have found that ivermectin is often very helpful in both long COVID and in post-COVID-vaccine CFS and fibromyalgia.

“I don’t know why. I simply know from treating people that it does.”

He said he can offer speculations, but they would simply be theories.

One study published in the American Journal of Therapeutics offers a hint. It finds that ivermectin exhibited antiviral activity against a wide range of RNA and DNA viruses, such as Zika, dengue, yellow fever, and others. The drug also showed specific action against SARS-CoV-2 in lab tests, with its potential mechanism of action being that it blocks viral proteins that suppress normal immune responses.

Teitelbaum said that what differentiates post-COVID-19 patients with CFS from patients with non-COVID-19-induced CFS is that “many improve considerably with the medication ivermectin.”

Besides ivermectin, there are many other approaches to treating post-COVID-19 CFS.

Natural Ways to Fight CFS

Research published in the Indian Journal of Tuberculosis finds that an effective CFS treatment is total rest—which means relaxing with no mental stimulation.

Study authors say those who have experienced post-COVID-19 CFS described lying in a darkened room for long periods to promote mental and physical rest.

Besides relaxation, they recommend using breathing and meditation apps and reducing any sensory input that makes you feel tense, such as noise and bright lights. Instead, expose yourself to things that are restful and relaxing, such as your favorite music or fragrance.

Another study found that 1,000 mg of the supplement oxaloacetate reduced physical and mental fatigue for CFS and long-COVID patients after six weeks of treatment.
Teitelbaum pointed out common supplements to treat CFS, which include:
  • NAC (N-acetylcysteine)
  • Glutathione
  • A multivitamin with zinc
  • Anti-inflammatories, such as highly absorbed curcumin and the herb Boswellia, that “shut down” inflammation and oxidative stress caused by the virus
Using these, along with the SHINE protocol, has resulted in many people improving their fatigue symptoms and enjoying an increase in quality of life, Teitelbaum said.

SHINE is an acronym for the five main areas of health that must be tended to. It stands for adequate Sleep, optimal Hormone levels, Immunity and underlying Infections, good Nutrition, and Exercise as able.

“Whether the CFS or fibromyalgia comes from COVID or other causes, these conditions are very treatable,” Teitelbaum said.

He emphasized that the problem isn’t a lack of effective treatments but the lack of effective physician education because the conditions are complex and because these treatments are low cost.

George Citroner reports on health and medicine, covering topics that include cancer, infectious diseases, and neurodegenerative conditions. He was awarded the Media Orthopaedic Reporting Excellence (MORE) award in 2020 for a story on osteoporosis risk in men.
Related Topics